Search research articles
Contact Us
Filters
Showing results (61-70 of 96) with videos related to
Page
of 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2012
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
E-F Solomayer, G Gebauer, P Hirnle, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma
T E Mürdter, W Schroth, L Bacchus-Gerybadze, et al.
Oncogene
|
December 14, 2011
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
I Keklikoglou, C Koerner, C Schmidt, et al.
Breast Cancer Research and Treatment
|
March 16, 2013
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
A D Hartkopf, M Banys, F Meier-Stiegen, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]
M Beckmann, C Sell, M Aydogdu, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 30, 2016
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]
M W Beckmann, C Sell, M Aydogdu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
G von Minckwitz, H Eidtmann, S Loibl, et al.
Translational Oncology
|
May 29, 2021
ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing
H Asperger, J-P Cieslik, B Alberter, et al.
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
November 30, 2010
[Are breast biopsies adequately funded? A process cost & revenue analysis]
M Hahn, E Fischbach, T Fehm, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 96) with videos related to
Sort By:
Page
of 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 3, 2012
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
E-F Solomayer, G Gebauer, P Hirnle, et al.
Clinical Pharmacology and Therapeutics
|
April 1, 2011
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma
T E Mürdter, W Schroth, L Bacchus-Gerybadze, et al.
Oncogene
|
December 14, 2011
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
I Keklikoglou, C Koerner, C Schmidt, et al.
Breast Cancer Research and Treatment
|
March 16, 2013
The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
A D Hartkopf, M Banys, F Meier-Stiegen, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
August 8, 2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]
M Beckmann, C Sell, M Aydogdu, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|
July 30, 2016
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]
M W Beckmann, C Sell, M Aydogdu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 14, 2010
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial
G von Minckwitz, H Eidtmann, S Loibl, et al.
Translational Oncology
|
May 29, 2021
ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing
H Asperger, J-P Cieslik, B Alberter, et al.
Clinical & Experimental Metastasis
|
October 17, 2018
Systematic analysis of parameters predicting pathological axillary status (ypN0 vs. ypN+) in patients with breast cancer converting from cN+ to ycN0 through primary systemic therapy (PST)
C Liedtke, Hans-Christian Kolberg, L Kerschke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
November 30, 2010
[Are breast biopsies adequately funded? A process cost & revenue analysis]
M Hahn, E Fischbach, T Fehm, et al.
Page
of 10